Delivery Order SPE2DB24D2215-SPE2DB24FGRZC
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a $11,610.44 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Ozempic 0.25-0.5 mg/dose pens. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,741.62 firm fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4564605282 OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML pharmaceutical product to the government. This delivery order contract is associated with Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract, valued at $5,102.97, is for the supply of Ozempic 0.25-0.5 mg/dose pens. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $28,637.28 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the provision of Ozempic 0.25-0.5 mg/dose pen 3 mL. This order is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables DLA to efficiently procure a comprehensive range of pharmaceutical products and medical...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $4,103.58 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply Ozempic 0.25-0.5 mg/dose pens. The contract has a completion date of February 21, 2024 and was awarded on February 20, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, to provide...
- The U.S. Defense Logistics Agency (DLA) has awarded a delivery order contract valued at $2,902.70 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of the pharmaceutical product Ozempic 0.25-0.5 mg/dose pen 3 mL. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of Ozempic 0.25-0.5 mg/dose pens. The $1,094.60 firm-fixed-price contract has a period of performance through September 16, 2024. Amerisourcebergen is a major pharmaceutical distributor that serves various federal agencies and healthcare programs. This contract is part of a larger $999,999,999 Indefinite Delivery Contract between Amerisourcebergen and the...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,741.62 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Ozempic 0.25-0.5 mg/dose pens. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC enables Amerisourcebergen to efficiently deliver a comprehensive range of pharmaceutical products and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract worth $1,952.72 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pen 3ml pharmaceutical products. This contract has an ultimate completion date of August 21, 2024 and is not set aside for any specific business category. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a $2,767.51 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens. The order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999, for providing a comprehensive range of pharmaceutical and medical products to support military treatment programs and facilities worldwide. The contract has no set-aside designation and is...
- SPE2DB24D2215Indefinite Delivery Contract
- SPE2DB24D2215-SPE2DB24FGRZCDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a $1,161.08 firm fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of Ozempic 0.25-0.5 mg/dose pens. This order is placed under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation. Amerisourcebergen also holds a smaller Indefinite Delivery Contract with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 6/12/24 |